Severe, refractory type II essential mixed cryoglobulinemia treated with 2-chlorodeoxyadenosine and mycophenolate mofetil

Douglas E. Gladstone, Marc G. Golightly, Kenneth W. Zamkoff

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Severe, refractory type II essential mixed cryoglobulinemia treated with 2-chlorodeoxyadenosine and mycophenolate mofetil'. Together they form a unique fingerprint.